NCT05095181已完成不适用
Preventive and Personalized Medicine (2021-2023)
Asfendiyarov Kazakh National Medical University1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2021年3月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- genotyping for the SNP associated with liver cirrhosis
研究概览
简要总结
The purpose of this study is to identify genetic determinants of susceptibility to liver cirrhosis . It will assist in predicting individual risks of disease progression and would help to clarify pathophysiologic mechanisms of liver cirrhosis .
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 60 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •hepatitis B
排除标准
- •the casual aget of liver disease is not viral infection, such as alcohol abuse
结局指标
主要结局
genotyping for the SNP associated with liver cirrhosis
时间窗: 1 year
Genotype frequency of SNP in the study genes of participants and control participants.
次要结局
未报告次要终点
研究者
Ildar Fakhradiyev
Head of the Laboratory of Experimental Medicine
Asfendiyarov Kazakh National Medical University
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)Liver CirrhosisNCT00709085National Taiwan University Hospital320
尚未招募
不适用
Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic AnemiaHemolytic Anemia, ChronicLiver DiseasesNCT06743854Assiut University58
已完成
不适用
Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLDHealthyNCT04494360Janssen Research & Development, LLC830
尚未招募
不适用
Research on the Clinical Characteristics and Key Diagnosis and Treatment Technology of Genetic and Metabolic Liver DiseaseDiagnosis , Treatment, Genetic and Metabolic Liver DiseaseNCT05601557Sujun Zheng480
已完成
不适用
Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)Primary Biliary CirrhosisNCT01161953Mayo Clinic1,500
